These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16474840)

  • 1. Decreased intranuclear mobility of acute myeloid leukemia 1-containing fusion proteins is accompanied by reduced mobility and compartmentalization of core binding factor beta.
    Qiu J; Wong J; Tweardy DJ; Dong S
    Oncogene; 2006 Jun; 25(28):3982-93. PubMed ID: 16474840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.
    Balkhi MY; Christopeit M; Chen Y; Geletu M; Behre G
    Exp Hematol; 2008 Nov; 36(11):1449-60. PubMed ID: 18687517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
    Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
    Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
    Fliegauf M; Stock M; Berg T; Lübbert M
    Oncogene; 2004 Dec; 23(56):9070-81. PubMed ID: 15489901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiation.
    Ibañez V; Sharma A; Buonamici S; Verma A; Kalakonda S; Wang J; Kadkol S; Saunthararajah Y
    Cancer Res; 2004 Jul; 64(13):4547-54. PubMed ID: 15231665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity.
    Liu Y; Cheney MD; Gaudet JJ; Chruszcz M; Lukasik SM; Sugiyama D; Lary J; Cole J; Dauter Z; Minor W; Speck NA; Bushweller JH
    Cancer Cell; 2006 Apr; 9(4):249-60. PubMed ID: 16616331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells.
    Li X; Xu YB; Wang Q; Lu Y; Zheng Y; Wang YC; Lübbert M; Zhao KW; Chen GQ
    J Cell Physiol; 2006 Sep; 208(3):594-601. PubMed ID: 16741927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemogenic AML1-ETO fusion protein increases carcinogen-DNA adduct formation with upregulated expression of cytochrome P450-1A1 gene.
    Xu M; Li D; Lu Y; Chen GQ
    Exp Hematol; 2007 Aug; 35(8):1249-55. PubMed ID: 17560011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AML1-ETO interacts with Sp1 and antagonizes Sp1 transactivity through RUNT domain.
    Wei H; Liu X; Xiong X; Wang Y; Rao Q; Wang M; Wang J
    FEBS Lett; 2008 Jun; 582(15):2167-72. PubMed ID: 18519037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 8;21 translocation in leukemogenesis.
    Peterson LF; Zhang DE
    Oncogene; 2004 May; 23(24):4255-62. PubMed ID: 15156181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterodimerization of AML1/ETO with CBFβ is required for leukemogenesis but not for myeloproliferation.
    Thiel VN; Giaimo BD; Schwarz P; Soller K; Vas V; Bartkuhn M; Blätte TJ; Döhner K; Bullinger L; Borggrefe T; Geiger H; Oswald F
    Leukemia; 2017 Nov; 31(11):2491-2502. PubMed ID: 28360416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis.
    Peterson LF; Lo MC; Okumura AJ; Zhang DE
    Blood Cells Mol Dis; 2007; 39(3):321-8. PubMed ID: 17692541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid maturation block by AML1-MTG16 is associated with Csf1r epigenetic downregulation.
    Rossetti S; Van Unen L; Touw IP; Hoogeveen AT; Sacchi N
    Oncogene; 2005 Aug; 24(34):5325-32. PubMed ID: 16007222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A distinct epigenetic signature at targets of a leukemia protein.
    Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
    BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of monoclonal antibodies to the AML1-ETO fusion protein: strategies for overcoming high homology.
    Simkins SG; Knapp SL; Brough GH; Lenz KL; Barley-Maloney L; Baker JP; Dekking L; Wai H; Dixon EP
    Hybridoma (Larchmt); 2011 Oct; 30(5):433-43. PubMed ID: 22008070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells.
    Nimer SD; Moore MA
    Oncogene; 2004 May; 23(24):4249-54. PubMed ID: 15156180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO.
    Lausen J; Liu S; Fliegauf M; Lübbert M; Werner MH
    Oncogene; 2006 Mar; 25(9):1349-57. PubMed ID: 16247445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETO interacting proteins.
    Hug BA; Lazar MA
    Oncogene; 2004 May; 23(24):4270-4. PubMed ID: 15156183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2.
    Ahmad F; Kokate P; Chheda P; Dalvi R; Das BR; Mandava S
    Cancer Genet Cytogenet; 2008 Jan; 180(2):153-7. PubMed ID: 18206543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction and tumorigenic study on a novel fusion gene AML1-MTG16].
    Wang Y; Lu S; Kong H; Wang L; Yuan W; Sun Y; Jing Y; Lu Z; Wang Z; Wang Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):271-5. PubMed ID: 12170460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.